Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bidlingmaier

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 5, 2009
Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's RegistryE Born-Frontsberg, M Reincke, L C Rump, et al.
The Journal of Clinical Endocrinology and Metabolism|April 28, 2012
Oral octreotide absorption in human subjects: comparable pharmacokinetics to parenteral octreotide and effective growth hormone suppressionS Tuvia, J Atsmon, S L Teichman, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Changes in non-22-kilodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult malesJ D Wallace, R C Cuneo, M Bidlingmaier, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
The response of molecular isoforms of growth hormone to acute exercise in trained adult malesJ D Wallace, R C Cuneo, M Bidlingmaier, et al.
The Journal of Clinical Endocrinology and Metabolism|September 15, 2005
Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levelsR A Feelders, M Bidlingmaier, C J Strasburger, et al.
BMC Endocrine Disorders|December 28, 2018
Obese adolescents exhibit a constant ratio of GH isoforms after whole body vibration and maximal voluntary contractionsA E Rigamonti, M Haenelt, M Bidlingmaier, et al.
European Journal of Endocrinology|April 13, 2012
Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studiesA Hannemann, M Bidlingmaier, N Friedrich, et al.
The New England Journal of Medicine|April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.
European Journal of Endocrinology|November 14, 2015
GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adultsD B Allen, P Backeljauw, M Bidlingmaier, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|January 25, 2012
[Multimorbidity and successful aging: the population-based KORA-Age study]A Peters, A Döring, K-H Ladwig, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|February 5, 2009
Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's RegistryE Born-Frontsberg, M Reincke, L C Rump, et al.
The Journal of Clinical Endocrinology and Metabolism|April 28, 2012
Oral octreotide absorption in human subjects: comparable pharmacokinetics to parenteral octreotide and effective growth hormone suppressionS Tuvia, J Atsmon, S L Teichman, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Changes in non-22-kilodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult malesJ D Wallace, R C Cuneo, M Bidlingmaier, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
The response of molecular isoforms of growth hormone to acute exercise in trained adult malesJ D Wallace, R C Cuneo, M Bidlingmaier, et al.
The Journal of Clinical Endocrinology and Metabolism|September 15, 2005
Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levelsR A Feelders, M Bidlingmaier, C J Strasburger, et al.
BMC Endocrine Disorders|December 28, 2018
Obese adolescents exhibit a constant ratio of GH isoforms after whole body vibration and maximal voluntary contractionsA E Rigamonti, M Haenelt, M Bidlingmaier, et al.
European Journal of Endocrinology|April 13, 2012
Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studiesA Hannemann, M Bidlingmaier, N Friedrich, et al.
The New England Journal of Medicine|April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.
European Journal of Endocrinology|November 14, 2015
GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adultsD B Allen, P Backeljauw, M Bidlingmaier, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|January 25, 2012
[Multimorbidity and successful aging: the population-based KORA-Age study]A Peters, A Döring, K-H Ladwig, et al.
Pageof 9